The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 270.00
Ask: 280.00
Change: 5.00 (1.85%)
Spread: 10.00 (3.704%)
Open: 265.00
High: 275.00
Low: 275.00
Prev. Close: 270.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Oct 2018 07:00

RNS Number : 8224E
Team17 Group PLC
23 October 2018
 

23 October 2018

 

Team17 Group plc 

("Team17", the "Group" or the "Company") 

 

Director change

 

Team17, a global games label, creative partner and developer of independent ("indie"), premium video games, today announces that Chief Financial Officer ("CFO"), Paul Bray, has decided to step down and retire, to spend more time with his family. Having joined Team17 in 2010, Paul has presided over a significant period of financial progress for the Group culminating in the successful listing on the AIM market of the London Stock Exchange in May 2018.

 

Simultaneously, the Company is pleased to announce the appointment of Jo Jones as CFO and a Director of the Company with immediate effect.

 

Jo has spent the last 10 years at Experian plc, working across a number of senior finance roles. Her most recent role at Experian was Finance Director of Service, Solutions, Technology & Transformation where she worked closely with Experian's UK Chief Information Officer and Chief Transformation Officer. Prior to that she was Finance Director of Decision Analytics & Marketing Services and Commercial Finance Director for UK and Ireland.

 

Jo has also held a number of finance roles with The Sytner Group Ltd, including Divisional Financial Controller for Daimler Chrysler and Lexus. She qualified as a chartered accountant at KPMG.

 

Paul will remain with the business until 30 November 2018 in order to facilitate an orderly handover.

 

Debbie Bestwick, Chief Executive of Team 17 commented:

 

"Firstly, let me personally thank Paul for his significant contribution to Team17 over the last eight years. Having supported me through the MBO and more recently our successful IPO, on behalf of everyone here at Team17, we wish Paul and his family well for the future.

 

"Secondly, let me welcome Jo into the Team17 family, we are delighted with her appointment. She joins our business at an incredibly exciting time and we look forward to her contribution in continuing our successful journey."

 

 

In accordance with Schedule 2(g) of the AIM Rules, Jo Jones (aged 40) holds or has held in the past 5 years the following directorships and partnerships:

 

Current

Past five years

 

Experian nominee at Greenwood Academies Trust (February to September 2018)

 

Save as disclosed above, no further information is required to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

For further information please contact:  

 

Team17 Group plc 

Debbie Bestwick MBE, Chief Executive Officer 

 

via Vigo Communications 

+44 (0)20 7390 0238 

GCA Altium (Nominated Adviser)

Phil Adams / Adrian Reed / Paul Lines 

 

+44 (0)845 505 4343 

Berenberg (Broker)

Chris Bowman / Toby Flaux / Marie-Agnes Stolberg 

 

+44 (0)20 3207 7800 

Vigo Communications (Financial Public Relations) 

Jeremy Garcia / Fiona Henson / Charlie Neish

team17@vigocomms.com

+44 (0)20 7390 0238 

 

NOTES TO EDITORS

Founded in 1990, Team17 Group plc is a leading international video games label and creative partner for independent developers. The portfolio comprises games such as The Escapists, Overcooked, Yoku's Island Express, Yooka-Laylee, My Time At Portia, the Worms franchise and many more from developers around the world. Visit www.team17.com for more info.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOALLFVAIDLFFIT
Date   Source Headline
16th Apr 20247:00 amRNSUnaudited Final Results 2023
12th Apr 20241:16 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSNotice of Analyst & Investor Meetings, FY Results
19th Mar 20243:29 pmRNSHoldings in Company
13th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 20248:58 amRNSNotice of Results
14th Feb 20241:00 pmRNSDirector/PDMR Shareholding
13th Feb 20244:28 pmRNSDirector/PDMR Shareholding
1st Feb 20241:10 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
19th Jan 20243:01 pmRNSHolding(s) in Company
12th Jan 20244:53 pmRNSHolding(s) in Company
12th Jan 20243:04 pmRNSHolding(s) in Company
11th Jan 20243:23 pmRNSDirector/PDMR Shareholding
14th Dec 20239:15 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSDirector Dealings
27th Nov 20237:00 amRNSDirector Dealings
24th Nov 20237:00 amRNSTrading Update
15th Nov 20233:29 pmRNSHolding(s) in Company
13th Nov 20234:57 pmRNSDirector/PDMR Shareholding
30th Oct 20233:51 pmRNSHolding(s) in Company
18th Oct 202312:41 pmRNSHolding(s) in Company
11th Oct 20235:14 pmRNSDirector/PDMR Shareholding
21st Sep 20231:06 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.